Alongside MS and glioma, our findings in AD show a relatively comparable effect, as elevated MR1 levels are correlated with increased Aβ only in the most vulnerable area—the CA1 region of the hippocampus [29]. This evidence concerns the gene MR1 and central nervous system cancer.